Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Pazopanib
Drug ID BADD_D01687
Description Pazopanib is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. It is developed by GlaxoSmithKline and was FDA approved on October 19, 2009.
Indications and Usage Treatment of advanced renal cell cancer and advanced soft tissue sarcoma (in patients previously treated with chemotherapy)
Marketing Status approved
ATC Code L01EX03
DrugBank ID DB06589
KEGG ID D05380
MeSH ID C516667
PubChem ID 10113978
TTD Drug ID Not Available
NDC Product Code Not Available
UNII 7RN5DR86CK
Synonyms pazopanib | GW 786034B | GW786034B | GW-786034B | GW 780604 | GW780604 | GW-780604 | Votrient
Chemical Information
Molecular Formula C21H23N7O2S
CAS Registry Number 444731-52-6
SMILES CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Gastric ulcer haemorrhage07.04.03.005; 24.07.02.0030.000112%-
Gastritis07.08.02.0010.000604%
Gastritis erosive07.04.03.0030.000112%-
Gastrointestinal fistula07.11.05.001--
Gastrooesophageal reflux disease07.02.02.0030.002899%
Gastrointestinal disorder07.11.01.001---
Gastrointestinal haemorrhage07.12.02.001; 24.07.02.009---
Gastrointestinal pain07.01.05.005--
Gastrointestinal perforation07.04.04.0010.000560%-
Generalised oedema08.01.07.004; 14.05.06.0070.000280%
Genital ulceration21.10.05.001; 23.07.03.0040.000302%-
Gingival bleeding07.09.07.001; 24.07.02.0100.000951%-
Gingival pain07.09.13.0100.000112%
Gingival swelling07.09.13.0130.000112%-
Gingivitis07.09.10.002; 11.01.04.013--
Glossitis07.14.01.0010.000548%-
Glossodynia07.14.02.0010.001421%-
Goitre05.02.01.001; 14.11.01.0080.000112%-
Groin pain15.03.02.0040.000302%-
Haematemesis07.12.02.002; 24.07.02.0110.001254%-
Haematochezia07.12.02.003; 24.07.02.0120.001198%-
Haematuria20.02.01.006; 21.10.01.018; 24.07.01.0470.001713%
Haemoglobin13.01.05.018---
Haemolytic uraemic syndrome01.06.02.001; 20.01.03.0110.000168%
Haemoptysis02.11.04.009; 22.02.03.004; 24.07.01.0060.002563%-
Haemorrhoids07.15.03.001; 24.10.02.0020.000694%
Haemothorax12.01.18.005; 22.05.02.001; 24.07.01.0080.000112%
Hair colour changes23.02.06.0010.033366%
Hair texture abnormal23.02.06.0040.000381%
Headache17.14.01.0010.020774%
The 6th Page    First    Pre   6 7 8 9 10    Next   Last    Total 21 Pages